Delivery Order SPE2DB22D9353-SPE2DB25FX2AT
- Not listed
- The U.S. Defense Logistics Agency has awarded a firm fixed-price delivery order contract worth $12,919.30 to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML syringes, and has a completion date of February 28, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, that DMS Pharmaceutical Group holds with the Defense Logistics Agency. The...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,253.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a completion date of August 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX15D9114|SPE2DX25F5ZHY) valued at $25,838.60 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EYLEA 2 MG/0.05 ML syringes. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) under the SPE2DB program, which enables the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products to support the medical supply needs of military...
- The U.S. Department of Defense's Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,761.76 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a medication, with a period of performance through September 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
- The Defense Logistics Agency issued a delivery order valued at $7,925.08 to DMS Pharmaceutical Group Inc. for EYLEA HD 8 mg/0.07 ml vials on July 25, 2025, with an ultimate completion date of August 15, 2025. EYLEA is a prescription pharmaceutical product used in the treatment of retinal diseases. This delivery order was issued under a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29.3 thousand by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract covers the delivery of EYLEA 2 mg/0.05 ml syringes to support federal healthcare requirements, with an ultimate completion date of August 18, 2025. This delivery order was issued without a set-aside designation and is...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,717.88 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a prescription drug product, with a completion date of March 25, 2024. This delivery order is issued under DMS Pharmaceutical Group's broader indefinite delivery contract 4600082013 with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on July 21, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and will be performed at the awardee's Park Ridge location. The order is funded through the Defense Logistics Agency's Medical...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $1,305.61 contract is for the delivery of EYLEA 2MG/0.05ML SY 1S pharmaceutical products with a completion date of February 13, 2024. This delivery order is issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract with DLA for a broad range of pharmaceutical items to support the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,919.30, is for the delivery of EYLEA 2 mg/0.05 ml syringes to support the medical supply needs of military health facilities. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2ATDelivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $24,446.00 for EYLEA 2 mg/0.05 mL syringes. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion comprehensive pharmaceutical supply agreement valid through November 2026 that enables the agency to procure a broad range of prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. EYLEA is a branded pharmaceutical product used primarily for ophthalmologic conditions. This delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its competitively awarded position to provide direct distribution of specialty pharmaceutical products to military health facilities. The company's successful track record with the DLA across multiple product categories, ranging from oncology treatments to vaccines and injections, demonstrates its capability to reliably fulfill specialized pharmaceutical procurement requirements for the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 7/31/25 |